Shenzhen Nuon Medical Equipment Co., Ltd. appears in FDA records as the legal applicant on 510(k) submissions for light-based hair growth devices. The most recent record in the supplied collection is K262183, a Traditional 510(k) received June 29, 2026 and decided September 24, 2026 as Substantially Equivalent for the Hair Growth Helmet family. An earlier clearance, K241342, covers the Hair Growth Comb (SZ-23, SZ-23A) and was decided November 8, 2024. Both filings sit in Class II under product code OAP, regulation number 890.5500, with the advisory committee listed as Physical Medicine. [1][2][5]

The 2026 Hair Growth Helmet clearance

K262183 covers a device family marketed as Hair Growth Helmet, with model designations TK-176, TK-600, TK-500, TK-282, TK-500A, TK-282A, TK-126 and TK-60. FDA's decision letter lists the trade name, regulation number 21 CFR 890.5500 and regulation name Infrared Lamp, and the record carries a decision date of September 24, 2026 with decision code SESE, described as Substantially Equivalent. The submission was received June 29, 2026, reviewed as a Traditional 510(k) without third-party review, and supported by a Summary rather than a statement. [1][2]

The decision letter addresses software as part of the review. FDA records that the device software was considered at a Basic Documentation Level because a malfunction or latent design flaw would lead to an erroneous diagnosis or a delay in delivery of appropriate medical care likely to result in Minor Injury. The letter also identifies the applicant contact as Anna He, Regulatory Affairs Manager, at the Shenzhen address on file. [2]

The 2024 Hair Growth Comb clearance

K241342 covers the Hair Growth Comb (SZ-23, SZ-23A) and was decided November 8, 2024. The decision letter names the same regulation, 21 CFR 890.5500 Infrared Lamp, Class II, product code OAP, and lists Alain Dijkstra as Regulatory Affairs Engineer at the Shenzhen address. The summary states that the proposed device uses technology similar to the predicate device and that the technology and design do not raise new types of questions regarding safety and effectiveness for the proposed indications for use. [5]

That summary identifies the predicate devices as K230579, K211038 and K222477 and carries a prepared date of November 7, 2024, version V5.0. The two clearances together show a documented pattern of hair growth devices filed under the same product code and regulation, with the helmet family following the comb by roughly two years. [5]

How the filings are counted

The linked-record collection for this company, retrieved November 20, 2026, contains one 510(k) record, K262183, and its decision count is one SESE. That single record is the entire linked collection in the snapshot; it is not a measure of total company sales, total portfolio or safety performance. A separate third-party index, Arca, states that as of November 18, 2026 FDA's public records list Shenzhen Nuon Medical Equipment with six 510(k) clearances, the most recent being the September 24, 2026 Hair Growth Helmet clearance. That count is Arca's published figure and is not reconciled against the linked-record collection. [1][6]

FDA.report's page for K262183 repeats the applicant name, product code OAP, regulation 890.5500, classification name Laser, Comb, Hair, device class 2, Traditional clearance type and Summary statement, and lists a separate OAP record from a different applicant, Dongguan Boyuan Intelligent Technology Co., Ltd, decided April 29, 2025. That neighboring record belongs to another company and does not describe Shenzhen Nuon's portfolio. [4]

Identity and open questions

The applicant name on the FDA correspondence is Shenzhen Nuon Medical Equipment Co., Ltd., with a Shenzhen, Guangdong address used for regulatory correspondence. That filing address is not evidence of a corporate headquarters, and no parent, brand or ownership relationship is verified in the available records. No website, customer list, certification, commercial availability or clinical performance data is documented here. [1][2][5]

The device names and model designations are the identities recorded in the FDA filings. What the filings establish is the regulatory route, the product code and regulation, the decision dates and the applicant of record; they do not establish clinical outcomes, patient selection criteria or treatment instructions, and none are stated here. [1][2][5]